Selected Publications

  1. Taggart, M., S. Holkup, A. Tchir, M. Mojoudi, A. Lyon, M. Hassan, C. Taveras, O. S. Ozgur, J. F. Markmann, H. Yeh, K. Uygun and A. Longchamp (2025). "UW supplementation with AP39 improves liver viability following static cold storage." Sci Rep 15(1): 1559.
  2. Yamamoto, T., N. Koizumi and J. F. Markmann (2025). "The Impact of Over Three Years Commercial Use of Ex Vivo Normothermic Machine Perfusion for Liver Transplantation in the USA: A UNOS/OPTN Database Analysis." Artif Organs.
  3. Sonnenberg, E. M. and J. F. Markmann (2025). "Machine Perfusion in Deceased Donor Kidney Transplantation: Promises of Improved Outcomes but Gaps in Implementation." Am J Kidney Dis.
  4. Vionnet, J., J. Torres-Yaguana, R. Miquel, J. G. Abraldes, J. Wall, E. Kodela, J. J. Lozano, P. Ruiz, M. Navasa, A. Marshall, F. Nevens, W. Gelson, J. Leithead, S. Masson, E. Jaeckel, R. Taubert, P. Tachtatzis, D. Eurich, K. J. Simpson, E. Bonaccorsi-Riani, J. Ferguson, A. Quaglia, A. J. Demetris, A. J. Lesniak, M. Elstad, M. Delord, A. Douiri, I. Rebollo-Mesa, M. Martinez-Llordella, J. A. F. Silva, J. F. Markmann and A. Sanchez-Fueyo (2024). "Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression." Am J Transplant.
  5. Lei J, Markmann JF: Clinical trials with stem cell-derived insulin-producing cells. Pluripotent Stem Cell Therapy for Diabetes. Piemonti L, Odorico J, Kieffer TJ, Sordi V, de Koning E (eds.). New York: Springer-Nature, Page: 547-571, 2024.
  6. Ben Nasr, M., V. Usuelli, S. Dellepiane, A. J. Seelam, T. V. Fiorentino, F. D'Addio, E. Fiorina, C. Xu, Y. Xie, H. B. Balasubramanian, E. Castillo-Leon, L. Loreggian, A. Maestroni, E. Assi, C. Loretelli, A. Abdelsalam, B. El Essawy, S. Uccella, I. Pastore, M. E. Lunati, G. Sabiu, A. Petrazzuolo, G. Ducci, E. Sacco, L. Centofanti, M. Venturini, S. Mazzucchelli, D. Mattinzoli, M. Ikehata, G. Castellano, G. Visner, L. Kaifeng, K. M. Lee, Z. Wang, D. Corradi, S. La Rosa, S. Danese, J. Yang, J. F. Markmann, G. V. Zuccotti, R. Abdi, F. Folli and P. Fiorina (2024). "Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule." Cell Metab 36(6): 1302-1319 e1312.
    Longchamp, A., T. Nakamura, K. Uygun and J. F. Markmann (2024). "Role of Machine Perfusion in Liver Transplantation." Surg Clin North Am 104(1): 45-65.
  7. Kojima, L., M. Akabane, M. Murray, M. Fruscione, D. Soma, A. Snyder, J. McVey, D. J. Firl, R. Hernandez-Alejandro, C. A. Kubal, J. F. Markmann, F. N. Aucejo, K. Tomiyama, S. Kimura and K. Sasaki (2024). "Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen." Liver Transpl.
  8. Mojoudi, M., M. Taggart, A. Karadagi, M. Hassan, T. Tomosugi, K. Tomofuji, T. Agius, A. Lyon, T. Nakamura, C. Taveras, O. S. Ozgur, A. Kharga, R. Matheson, L. V. Riella, S. Kimura, H. Yeh, J. F. Markmann, T. Kawai, K. Uygun and A. Longchamp (2024). "Two-day Static Cold Preservation of alpha1,3-Galactosyltransferase Knockout Kidney Grafts Before Simulated Xenotransplantation." Xenotransplantation 31(4): e12879.
  9. LeGuern, C. and J. F. Markmann (2024). "Regulatory CD4(+) T cells: permanent or temporary suppressors of immunity." Front Immunol 15: 1293892.
  10. Markmann, J. F., B. E. Burrell, J. S. Bromberg, C. Hartono, D. B. Kaufman, A. M. Possselt, A. Naji, N. D. Bridges, C. Breeden, S. Kanaparthi, J. Pardo, H. Kopetskie, K. Mason, N. Lim and S. Chandran (2024). "Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial." Am J Transplant. (Markmann, Burrell et al. 2024)
  11. Mahboub, P., M. Aburawi, O. S. Ozgur, C. Pendexter, S. Cronin, F. M. Lin, R. Jain, M. N. Karabacak, N. Karimian, S. N. Tessier, J. F. Markmann, H. Yeh and K. Uygun (2024). "Gradual rewarming with a hemoglobin-based oxygen carrier improves viability of donation after circulatory death in rat livers." Front Transplant 3: 1353124.
  12. Longchamp, A., F. M. Fontan, M. M. Aburawi, C. Eymard, N. Karimian, D. Detelich, C. Pendexter, S. Cronin, T. Agius, S. Nagpal, P. D. Banik, S. N. Tessier, S. Ozer, F. L. Delmonico, K. Uygun, H. Yeh and J. F. Markmann (2024). "Acellular Perfusate is an Adequate Alternative to Packed Red Blood Cells During Normothermic Human Kidney Perfusion." Transplant Direct 10(4): e1609.
  13. Longchamp, A., F. M. Fontan, M. M. Aburawi, C. Eymard, N. Karimian, D. Detelich, C. Pendexter, S. Cronin, T. Agius, S. Nagpal, P. D. Banik, S. N. Tessier, S. Ozer, F. L. Delmonico, K. Uygun, H. Yeh and J. F. Markmann (2024). "Acellular Perfusate is an Adequate Alternative to Packed Red Blood Cells During Normothermic Human Kidney Perfusion." Transplant Direct 10(4): e1609.
  14. Longchamp, A. and J. F. Markmann (2023). "Kidney Preservation Strategies to Improve Transplant Outcomes." Clin J Am Soc Nephrol 18(12): 1628-1630.
  15. Yamamoto, T., S. Atthota, D. Agarwal, K. Crisalli, M. MacConmara, T. Nakamura, R. Teo, L. A. Dageforde, S. Kimura, N. Elias, H. Yeh, A. Bozorgzadeh, T. Kawai and J. F. Markmann (2023). "Impact of Portable Normothermic Machine Perfusion for Liver Transplantation From Adult Deceased Donors." Ann Surg 278(5): e922-e929.
  16. Nakamura, T., K. Sasaki, L. Kojima, R. Teo, Y. Inaba, T. Yamamoto, S. Kimura, L. A. Dageforde, H. Yeh, N. Elias, A. Bozorgzadeh, T. Kawai and J. F. Markmann (2023). "Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death." Clin Transplant 37(8): e14989.
  17. Cheng H, Hua L, Tang H, Bao Z, Xu X, Zhu H, Wang S, Jiapaer Z, Bhatia R, Dunn IF, Deng J, Wang D, Sun S, Luan S, Ji J, Xie Q, Yang X, Lei Ji, Guoping Li, Xianli Wang, and Ye Gong. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis. J Mol Cell Biol. 2023. doi: 10.1093/jmcb/mjad057. PubMed PMID: 37791390. 
  18. Guinan, E. C., L. Contreras-Ruiz, K. Crisalli, C. Rickert, I. Rosales, R. Makar, R. Colvin, E. K. Geissler, B. Sawitzki, P. Harden, Q. Tang, G. Blancho, L. A. Turka and J. F. Markmann (2023). "Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial." Am J Transplant 23(12): 1872-1881.
  19. Deng, H., A. Zhang, D. R. R. Pang, Y. Xi, Z. Yang, R. Matheson, G. Li, H. Luo, K. M. Lee, Q. Fu, Z. Zou, T. Chen, Z. Wang, I. A. Rosales, C. W. Peters, J. Yang, M. M. Coronel, E. S. Yolcu, H. Shirwan, A. J. Garcia, J. F. Markmann and J. Lei (2023). "Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates." Cell Rep Med 4(3): 100959.
  20. Adams, A., L. C. Cendales, D. K. C. Cooper, E. Cozzi, J. Gill, E. Judd, E. Katz, A. D. Kirk, J. A. Fishman, P. P. Reese, A. Wall and J. F. Markmann (2023). "American Society of Transplant Surgeons-American Society of Transplantation report of FDA meeting on regulatory expectations for xenotransplantation products." Am J Transplant 23(9): 1290-1299.
  21. Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant De, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Chen X, Friberg AS, Lei Ji, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AM, Chen X. National Institutes of Health-sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: manufacture of a complex cellular product at eight processing facilities. Diabetes 2016;65(11):3418-28. PMID: 27465220. PMCID: PMC5079635.
  22. Wang LJ, Kin T, O'Gorman D, Shapiro AM, Naziruddin B, Takita M, Levy MF, Posselt AM, Szot GL, Savari O, Barbaro B, McGarrigle J, Yeh CC, Oberholzer J, Lei Ji, Chen T, Lian M, Markmann JF, Alvarez A, Linetsky E, Ricordi C, Balamuruggan AN, Loganathan G, Wilhelm JJ, Hering BJ, Bottino R, Trucco M, Liu C, Min Z, Li Y, Naji A, Fernandez LA, Ziemelis M, Danobeitia JS, Millis M, Witkowski P. A multicenter study: North American islet donor score in donor pancreas selection for human islet isolation for transplantation. Cell Transplant 2016;25(8):1515-23. PMID: 26922947. PMCID: PMC5167495.
  23. Lei Ji, Markmann JF, McCoy CS, Luo H, Harrington EP, Rosales I. Heterotopic ossification of laparotomy scars in a nonhuman primate. J Surgery 2017: J117.
  24. Oura T, Hotta K, Lei Ji, Markmann J, Rosales I, Dehnadi A, Kawai K, Ndishibandi D, Smith RN, Cosimi AB, Kawai T. Immunosuppression with CD40 costimulatory blockade plus rapamycin for simultaneous islet-kidney transplantation in nonhuman primates. Am J Transplant 2017;17(3):646-56. PMID: 27501203. PMCID: PMC5298941.
  25. Schuetz C, Lee KM, Scott R, Kojima L, Washburn L, Liu L, Tector H, Lei Ji, Yeh H, Kim JI, Markmann JF. Reglaatory Breg dependent islet transplant tolerance is also natural killer cell dependent. Am J Transplant 2017;17(6):1656-62. PMID: 28296255. PMCID: PMC5444975.
  26. Rezanejad H, Ouziel-Yahalom L, Keyzer CA, Sullivan BA, Hollister-Lock J, Li WC, Guo L, Deng S, Lei Ji, Markmann J, Bonner-Weir S. Heterogeneity of SOX9 and HNF1beta in Pancreatic Ducts Is Dynamic. Stem Cell Reports. 2018;10(3):725-38. doi: 10.1016/j.stemcr.2018.01.028. PubMed PMID: 29478894; PMCID: PMC5918495.
  27. Marinko Sremac, Lei Ji, Madeline FE Penson, Christian Schuetz, Jonathan RT Lakey, Klearchos K Papas, Pushkar S Varde, Paul de Vos, Timothy Brauns, James Markmann, Mark C Poznansky, Preliminary studies of the impact of CXCL12 on the foreign body reaction to pancreatic islets microencapsulated in alginate in non-human primates; 2019 Transplant Direct,5: e447.
  28. Lei Ji, Alexander Zhang1, Hongping Deng1, Zhihong Yang1, Cole W. Peters1, Kang M. Lee1 Zhenjuan Wang1, Ivy A. Rosales2, Charles Rickert1, James F. Markmann, Intrapleural Transplantation of Allogeneic Pancreatic Islets Achieves Glycemic Control in a Diabetic Non-Human Primate. Am J Transplant 2021, 12/27, DOI: 10.1111/ajt.16875
  29. Lei Ji, Coronel MM, Yolcu ES, Deng H, Grimany-Nuno O, Hunckler MD, Ulker V, Yang Z, Lee KM, Zhang A, Luo H, Peters CW, Zou Z, Chen T, Wang Z, McCoy CS, Rosales IA, Markmann JF, Shirwan H, Garcia AJ. FasL microgels induce immune acceptance of islet allografts in nonhuman primates. Sci Adv 2022;8(19):eabm9881. doi: 10.1126/sciadv. abm9881. PubMed PMID: 35559682.
  30. Lee KM, Fu Q, Huai G, Deng K, Lei Ji, Kojima L, Agarwal D, van Galen P, Kimura S, Tanimine N, Washburn L, Yeh H, Naji A, Rickert CG, LeGuern C, Markmann JF. Suppression of allograft rejection by regulatory B cells induced via TLR signaling. JCI Insight, 2022;7(17). doi: 10.1172/jci.insight.152213. PubMed PMID: 35943811; PMCID: PMC9536278.
  31. Kazuhiko Yamada DLE, Xiaojuan Chen, Lei Ji, Michelle R. Santillan & Anna Moore Vascularized Islet Transplantation as Composite Islet-Kidney Grafts with Nanoparticle-Labeled Islets in Large Animal Preclinical Transplant Models. Methods in Molecular Biology. 2022; 2592.
  32. Yang, X., P. Gokulnath, H. I. Lehmann, Z. Hou, S. Yang, L. You, G. Zhang, Y. Xing, Lei Ji, G. Li, S. Guo and H. Shang. "RNA modifications in aging-associated cardiovascular diseases." Aging (Albany NY); 14(19): 8110-8136. 2022)
  33. Zhang Y, Yang M, Jia G, Deng S, Lei Ji, Markmann J, Zhao G. In vivo induction of regulatory T cells by anti-CD45RB antibody causes transferable tolerance to discordant human xenogenic islets. Xenotransplantation. 2022, e12778. doi: 10.1111/xen.12778. PubMed PMID: 36125404.)
  34. Zeyidan Jiapaer, Chengyu Li, Xinyu Yang, Tiffaney Hsia, Emeli Chatterjee, Lingying Zhang, Lei Ji, Guoping Li. Non-Coding RNAs in Cardiovascular Diseases. Pharmaceutics 2023;15(1).
  35. Hongping Deng, Alexander Zhang, Dillon Ren Rong Pang, Yinsheng Xi, Zhihong Yang, Rudy Matheson, Guoping Li, Hao Luo, Kang M. Lee, Qiang Fu, Zhongliang Zou, Tao Chen, Zhenjuan Wang, Ivy A. Rosales, Cole W. Peters, Jibing Yang, María M. Coronel, Esma S. Yolcu, Haval Shirwan, Andrés J. García, James F. Markmann, Lei Ji. Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates. Cell Rep Med 2023:100959.
  36. Rickert, C. G. and J. F. Markmann (2022). "Transplantation in the Age of Precision Medicine: The Emerging Field of Treg Therapy." Semin Nephrol 42(1): 76-85.
  37. Lee, K. M., Q. Fu, G. Huai, K. Deng, J. Lei, L. Kojima, D. Agarwal, P. van Galen, S. Kimura, N. Tanimine, L. Washburn, H. Yeh, A. Naji, C. G. Rickert, C. LeGuern and J. F. Markmann (2022). "Suppression of allograft rejection by regulatory B cells induced via TLR signaling." JCI Insight 7(17).
  38. Yamamoto, T., A. Shah, M. Fruscione, S. Kimura, N. Elias, H. Yeh, T. Kawai and J. F. Markmann (2022). "Revisiting the "Weekend Effect" on Adult and Pediatric Liver and Kidney Offer Acceptance." Ann Transplant 27: e937825.
  39. Firl, D. J. and J. F. Markmann (2022). "Reply to "Letter to the editor in response to: Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants"." Am J Transplant 22(9): 2279-2280.
  40. Markmann, J. F., P. A. Vagefi and M. P. MacConmara (2022). "Normothermic Machine Perfusion Increases Donor Liver Use." JAMA Surg 157(8): 742-743.
  41. Firl, D. J. and J. F. Markmann (2022). "Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants." Am J Transplant 22(6): 1527-1536.
  42. Lei, J., A. Zhang, H. Deng, Z. Yang, C. W. Peters, K. M. Lee, Z. Wang, I. A. Rosales, C. G. Rickert and J. F. Markmann (2022). "Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non-human primate." Am J Transplant 22(3): 966-972.
  43. Markmann, J. F., M. S. Abouljoud, R. M. Ghobrial, C. S. Bhati, S. J. Pelletier, A. D. Lu, S. Ottmann, T. Klair, C. Eymard, G. R. Roll, J. Magliocca, T. L. Pruett, J. Reyes, S. M. Black, C. L. Marsh, G. Schnickel, M. Kinkhabwala, S. S. Florman, S. Merani, A. J. Demetris, S. Kimura, M. Rizzari, A. Saharia, M. Levy, A. Agarwal, F. G. Cigarroa, J. D. Eason, S. Syed, W. K. Washburn, J. Parekh, J. Moon, A. Maskin, H. Yeh, P. A. Vagefi and M. P. MacConmara (2022). "Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial." JAMA Surg 157(3): 189-198.
  44. Kazuhiko Yamada DLE, Xiaojuan Chen, Lei Ji, Michelle R. Santillan & Anna Moore Vascularized Islet Transplantation as Composite Islet-Kidney Grafts with Nanoparticle-Labeled Islets in Large Animal Preclinical Transplant Models. Methods in Molecular Biology. 2022; 2592.
  45. Yang, X., P. Gokulnath, H. I. Lehmann, Z. Hou, S. Yang, L. You, G. Zhang, Y. Xing, Lei Ji, G. Li, S. Guo and H. Shang. "RNA modifications in aging-associated cardiovascular diseases." Aging (Albany NY); 14(19): 8110-8136. 2022)
  46. Zhang Y, Yang M, Jia G, Deng S, Lei Ji, Markmann J, Zhao G. In vivo induction of regulatory T cells by anti-CD45RB antibody causes transferable tolerance to discordant human xenogenic islets. Xenotransplantation. 2022, e12778. doi: 10.1111/xen.12778. PubMed PMID: 36125404.)
  47. Lei Ji, Coronel MM, Yolcu ES, Deng H, Grimany-Nuno O, Hunckler MD, Ulker V, Yang Z, Lee KM, Zhang A, Luo H, Peters CW, Zou Z, Chen T, Wang Z, McCoy CS, Rosales IA, Markmann JF, Shirwan H, Garcia AJ. FasL microgels induce immune acceptance of islet allografts in nonhuman primates. Sci Adv 2022;8(19):eabm9881. doi: 10.1126/sciadv. abm9881. PubMed PMID: 35559682.  
  48. Lee KM, Fu Q, Huai G, Deng K, Lei Ji, Kojima L, Agarwal D, van Galen P, Kimura S, Tanimine N, Washburn L, Yeh H, Naji A, Rickert CG, LeGuern C, Markmann JF. Suppression of allograft rejection by regulatory B cells induced via TLR signaling. JCI Insight, 2022;7(17). doi: 10.1172/jci.insight.152213. PubMed PMID: 35943811; PMCID: PMC9536278.
  49. Martins, P. N., I. M. A. Bruggenwirth, J. McDaid, M. Hertl, T. Kawai, N. Elias, R. T. Chung and J. F. Markmann (2022). "Heat Stroke as a Cause of Liver Failure and Evaluation of Liver Transplant." Exp Clin Transplant 20(6): 621-626.
  50. Lei Ji, Alexander Zhang1, Hongping Deng1, Zhihong Yang1, Cole W. Peters1, Kang M. Lee1 Zhenjuan Wang1, Ivy A. Rosales2, Charles Rickert1, James F. Markmann, Intrapleural Transplantation of Allogeneic Pancreatic Islets Achieves Glycemic Control in a Diabetic Non-Human Primate. Am J Transplant 2021, 12/27, DOI: 10.1111/ajt.16875
  51. Williams, W. W. and J. F. Markmann (2021). "Warming Up to Cold Perfusion." N Engl J Med 384(15): 1458-1459.
  52. Haque, O., S. Raigani, I. Rosales, C. Carroll, T. M. Coe, S. Baptista, H. Yeh, K. Uygun, F. L. Delmonico and J. F. Markmann (2021). "Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury." Front Surg 8: 644859.
  53. Yuan, Q., O. Haque, T. M. Coe and J. F. Markmann (2021). "The Heterogenous Effect of COVID-19 on Liver Transplantation Activity and Waitlist Mortality in the United States." Front Surg 8: 669129.
  54. Fu, Q., K. M. Lee, G. Huai, K. Deng, D. Agarwal, C. G. Rickert, N. Feeney, R. Matheson, H. Yang, C. LeGuern, S. Deng and J. F. Markmann (2021). "Properties of regulatory B cells regulating B cell targets." Am J Transplant 21(12): 3847-3857.
  55. Markmann, J. F., M. R. Rickels, T. L. Eggerman, N. D. Bridges, D. E. Lafontant, J. Qidwai, E. Foster, W. R. Clarke, M. Kamoun, R. Alejandro, M. D. Bellin, K. Chaloner, C. W. Czarniecki, J. S. Goldstein, B. J. Hering, L. G. Hunsicker, D. B. Kaufman, O. Korsgren, C. P. Larsen, X. Luo, A. Naji, J. Oberholzer, A. M. Posselt, C. Ricordi, P. A. Senior, A. M. J. Shapiro, P. G. Stock and N. A. Turgeon (2021). "Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes." Am J Transplant 21(4): 1477-1492.
  56. Haque, O., Q. Yuan, K. Uygun and J. F. Markmann (2021). "Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come." Clin Transplant 35(3): e14211.
  57. Tanimine, N., B. E. Burrell, K. Deng, C. Rickert, K. M. Lee, N. Feeney, J. Pardo, C. LeGuern and J. F. Markmann (2021). "Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells." J Immunol Methods 491: 112987.
  58. Fu, Q., D. Agarwal, K. Deng, R. Matheson, H. Yang, L. Wei, Q. Ran, S. Deng and J. F. Markmann (2021). "An Unbiased Machine Learning Exploration Reveals Gene Sets Predictive of Allograft Tolerance After Kidney Transplantation." Front Immunol 12: 695806.
  59. Kimura, S., C. G. Rickert, L. Kojima, M. Aburawi, N. Tanimine, F. Fontan, K. Deng, H. Tector, K. Mi Lee, H. Yeh and J. F. Markmann (2020). "Regulatory B cells require antigen recognition for effective allograft tolerance induction." Am J Transplant 20(4): 977-987.
  60. Coe, T. M., M. Tanaka, E. D. Bethea, D. A. D'Alessandro, S. Kimura, H. Yeh and J. F. Markmann (2020). "Liver transplantation with suprahepatic caval anastomosis including inferior vena cava stent." Transpl Rep 5(4).
  61. Aburawi, M. M., F. M. Fontan, N. Karimian, C. Eymard, S. Cronin, C. Pendexter, S. Nagpal, P. Banik, S. Ozer, P. Mahboub, F. L. Delmonico, H. Yeh, K. Uygun and J. F. Markmann (2019). "Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion." Am J Transplant 19(10): 2814-2824.
  62. Fu, Q., F. Yang, M. Liao, N. J. Feeney, K. Deng, N. Serifis, L. Wei, H. Yang, K. Chen, S. Deng and J. F. Markmann (2019). "Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation." Front Oncol 9: 737.
  63. Marinko Sremac, Lei Ji, Madeline FE Penson, Christian Schuetz, Jonathan RT Lakey, Klearchos K Papas, Pushkar S Varde, Paul de Vos, Timothy Brauns, James Markmann, Mark C Poznansky, Preliminary studies of the impact of CXCL12 on the foreign body reaction to pancreatic islets microencapsulated in alginate in non-human primates; 2019 Transplant Direct,5: e447.
  64. Martins, P. N., T. A. Berendsen, H. Yeh, B. G. Bruinsma, M. L. Izamis, S. Op den Dries, A. R. Gillooly, R. Porte, M. L. Yarmush, K. Uygun and J. F. Markmann (2019). "Oxygenated UW Solution Decreases ATP Decay and Improves Survival After Transplantation of DCD Liver Grafts." Transplantation 103(2): 363-370.
  65. Rickert, C. G. and J. F. Markmann (2019). "Current state of organ transplant tolerance." Curr Opin Organ Transplant 24(4): 441-450.
  66. Detelich, D. and J. F. Markmann (2018). "The dawn of liver perfusion machines." Curr Opin Organ Transplant 23(2): 151-161.
  67. Markmann, J. F. (2018). "Relaxing liver ischemia reperfusion injury down 1 notch." Am J Transplant 18(7): 1587-1588.
  68. Detelich, D. and J. F. Markmann (2018). "Normothermic liver preservation, current status and future directions." Curr Opin Organ Transplant 23(3): 347-352.
  69. Markmann, J. F. (2018). "Commentary on Nurse Telephonic Triage Service for After-hour Patient Calls in Neurosurgery." Ann Surg 267(4): e69.
  70. Rezanejad H, Ouziel-Yahalom L, Keyzer CA, Sullivan BA, Hollister-Lock J, Li WC, Guo L, Deng S, Lei Ji, Markmann J, Bonner-Weir S. Heterogeneity of SOX9 and HNF1beta in Pancreatic Ducts Is Dynamic. Stem Cell Reports. 2018;10(3):725-38. doi: 10.1016/j.stemcr.2018.01.028. PubMed PMID: 29478894; PMCID: PMC5918495.
  71. Markmann, J. F. and H. Yeh (2017). "The Beginnings of a Transplant Revolution." Ann Surg 265(1): e3.
  72. Schuetz, C., K. M. Lee, R. Scott, L. Kojima, L. Washburn, L. Liu, W. H. Liu, H. Tector, J. Lei, H. Yeh, J. I. Kim and J. F. Markmann (2017). "Regulatory B Cell-Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent." Am J Transplant 17(6): 1656-1662.
  73. Lei Ji, Markmann JF, McCoy CS, Luo H, Harrington EP, Rosales I.  Heterotopic ossification of laparotomy scars in a nonhuman primate. J Surgery 2017: J117.
  74. Oura T, Hotta K, Lei Ji, Markmann J, Rosales I, Dehnadi A, Kawai K, Ndishibandi D, Smith RN, Cosimi AB, Kawai T. Immunosuppression with CD40 costimulatory blockade plus rapamycin for simultaneous islet-kidney transplantation in nonhuman primates. Am J Transplant 2017;17(3):646-56. PMID: 27501203. PMCID: PMC5298941.
  75. Schuetz C, Lee KM, Scott R, Kojima L, Washburn L, Liu L, Tector H, Lei Ji, Yeh H, Kim JI, Markmann JF. Reglaatory Breg dependent islet transplant tolerance is also natural killer cell dependent. Am J Transplant 2017;17(6):1656-62. PMID: 28296255. PMCID: PMC5444975.
  76. Heher, E. and J. F. Markmann (2016). "The Clearer BENEFITS of Belatacept." N Engl J Med 374(4): 388-389.
  77. Markmann, J. F. (2016). "Signatures of Tolerance or Immunosuppression?" Am J Transplant 16(12): 3320-3321.
  78. Markmann, J. F. (2016). "Isolated Pancreatic Islet Transplantation: A Coming of Age." Am J Transplant 16(2): 381-382.
  79. Schuetz, C. and J. F. Markmann (2016). "Islet cell transplant: Update on current clinical trials." Curr Transplant Rep 3(3): 254-263.
  80. Sanchez-Fueyo, A. and J. F. Markmann (2016). "Immune Exhaustion and Transplantation." Am J Transplant 16(7): 1953-1957.
  81. Markmann, J. F., S. T. Bartlett, P. Johnson, O. Korsgren, B. J. Hering, D. Scharp, T. W. Kay, J. Bromberg, J. S. Odorico, G. C. Weir, N. Bridges, R. Kandaswamy, P. Stock, P. Friend, M. Gotoh, D. K. Cooper, C. G. Park, P. J. O'Connell, C. Stabler, S. Matsumoto, B. Ludwig, P. Choudhary, B. Khovatchev, M. R. Rickels, M. Sykes, K. Wood, K. Kraemer, A. Hwa, E. Stanley, C. Ricordi, M. Zimmerman, J. Greenstein, E. Montanya and T. Otonkoski (2016). "Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of beta-Cell Replacement." Transplantation 100(7): e25-31.
  82. Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant De, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Chen X, Friberg AS, Lei Ji, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AM, Chen X. National Institutes of Health-sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: manufacture of a complex cellular product at eight processing facilities. Diabetes 2016;65(11):3418-28. PMID: 27465220. PMCID: PMC5079635.
  83. Wang LJ, Kin T, O'Gorman D, Shapiro AM, Naziruddin B, Takita M, Levy MF, Posselt AM, Szot GL, Savari O, Barbaro B, McGarrigle J, Yeh CC, Oberholzer J, Lei Ji, Chen T, Lian M, Markmann JF, Alvarez A, Linetsky E, Ricordi C, Balamuruggan AN, Loganathan G, Wilhelm JJ, Hering BJ, Bottino R, Trucco M, Liu C, Min Z, Li Y, Naji A, Fernandez LA, Ziemelis M, Danobeitia JS, Millis M, Witkowski P. A multicenter study: North American islet donor score in donor pancreas selection for human islet isolation for transplantation. Cell Transplant 2016;25(8):1515-23. PMID: 26922947. PMCID: PMC5167495.
  84. Kim, J. I., D. M. Rothstein and J. F. Markmann (2015). "Role of B cells in tolerance induction." Curr Opin Organ Transplant 20(4): 369-375.
  85. Lei, J., J. I. Kim, S. Shi, X. Zhang, Z. Machaidze, S. Lee, C. Schuetz, P. N. Martins, T. Oura, E. A. Farkash, I. A. Rosales, R. N. Smith, R. Stott, K. M. Lee, J. Soohoo, S. Boskovic, K. Cappetta, O. M. Nadazdin, Y. Yamada, H. Yeh, T. Kawai, D. H. Sachs, G. Benichou and J. F. Markmann (2015). "Pilot Study Evaluating Regulatory T Cell-Promoting Immunosuppression and Nonimmunogenic Donor Antigen Delivery in a Nonhuman Primate Islet Allotransplantation Model." Am J Transplant 15(10): 2739-2749.
  86. Schuetz, C. and J. F. Markmann (2015). "Immunogenicity of beta-cells for autologous transplantation in type 1 diabetes." Pharmacol Res 98: 60-68.
  87. Chen T, Yuan J, Duncanson S, Hibert ML, Kodish BC, Mylavaganam G, Maker M, Li H, Sremac M, Santosuosso M, Forbes B, Kashiwagi S, Cao J, Lei Ji, Thomas M, Hartono C, Sachs D, Markmann J, Sambanis A, Poznansky MC.  Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression. Am J Transplant 2015;15(3):618-27. PMID: 25693473.
  88. Lei Ji, Kim JI, Shi S, Zhang X, Machaidze Z, Lee S, Schuetz C, Martins PN, Oura T, Farkash EA, Rosales IA, Smith RN, Stott R, Lee KM, Soohoo J, Boskovic S, Cappetta K, Nadazdin OM, Yamada Y, Yeh H, Kawai T, Sachs DH, Benichou G, Markmann JF. Pilot study evaluating regulatory T cell-promoting immunosuppression and nonimmunogenic donor antigen delivery in a nonhuman primate islet allotransplantation model. Am J Transplant 2015;15(10):2739-49. PMID: 26014796
  89. Caballero F, Siniakowicz K, Hollister-Lock J, Duran L, Katsuta H, Yamada T, Lei Ji, Deng S, Westermark, GT, Markmann J, Bonner-Weir S, Weir GC. Birth and death of human beta-cells in pancreases from cadaver donors, autopsies, surgical specimens, and islets transplanted into mice. Cell Transplant 2014;23(2):139-51. PMID: 23321263. PMCID: PMC3947859.
  90. Corritore E, Dugnani E, Pasquale V, Misawa R, Witkowski P, Lei Ji, Markmann J, Piemonti L, Sokal EM, Bonner-Weir S, Lysy PA. Beta-Cell differentiation of human pancreatic duct-derived cells after in vitro expansion. Cellular Reprogram 2014;16(6):456-66. PMID: 25437872. PMCID: PMC4298753.
  91. Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM, Lei Ji, Deng S, Yeh H, Markmann JF, Kim JI. TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 2014;44(6):1728-36. PMID: 24700192. PMCID: 4048633.
  92. Zhao G, Moore DJ, Kim JI, Lee KM, O'Connor M, Yang M, Lei Ji, Schuetz C, Markmann JF, Deng S. An immunosufficient murine model for the study of human islets. Xenotransplantation 2014;21(6):567-73. PMID: 25041432. PMCID: PMC4262653.
  93. Axelrod, D, Smith, K, Chaidarun, S, Markmann, J, Lei, Ji,  Freeman, R, Gardner, T. Total Pancreatectomy With Auto Islet Transplantation Using Offsite Recovery of Islets. Transplantation: July 15, 2014 - Volume 98 - Issue - p 210
  94. Schuetz, C, Lei, Ji, Machaidze, Z, Saidman, S, Yeh, H, Kim, J, Shi, S,  Zhang, X, Wei, L,  Soohoo, J, Wang, T, Markmann, J. Challenges in Pre-Clinical Transplantation of Encapsulated Xenogenic Islets. Transplantation: July 15, 2014 - Volume 98 - Issue - p 332
  95. Vagefi, P. A. and J. F. Markmann (2014). "Liver transplantation: it's all about location, location, location: in reply to Lee and colleagues." J Am Coll Surg 219(5): 1100-1101.
  96. Yeh, H., Z. Machaidze, I. Wamala, J. W. Fraser, N. Navarro-Alvarez, K. Kim, C. Schuetz, S. Shi, A. Zhu, M. Hertl, N. Elias, E. A. Farkash, P. A. Vagefi, M. Varma, R. N. Smith, S. C. Robson, E. M. Van Cott, D. H. Sachs and J. F. Markmann (2014). "Increased transfusion-free survival following auxiliary pig liver xenotransplantation." Xenotransplantation 21(5): 454-464.
  97. Martins, P. N., S. G. Tullius and J. F. Markmann (2014). "Immunosenescence and immune response in organ transplantation." Int Rev Immunol 33(3): 162-173.
  98. Kitchens, W. H., H. Yeh and J. F. Markmann (2014). "Hepatic retransplant: what have we learned?" Clin Liver Dis 18(3): 731-751.
  99. Yeh, H. and J. F. Markmann (2013). "Transplantation: Are calcineurin inhibitors safer than mTOR inhibitors?" Nat Rev Nephrol 9(1): 11-13.
  100. Martins, P. N., J. McDaid and J. F. Markmann (2013). "Left accessory hepatic artery damage by a misplaced gastric band in a deceased liver donor." Transplantation 96(6): e45-46.
  101. Barker, C. F. and J. F. Markmann (2013). "Historical overview of transplantation." Cold Spring Harb Perspect Med 3(4): a014977.
  102. Kim, J. I., R. T. Stott, J. Soohoo, K. M. Lee, G. Zhao, H. Yeh, S. Deng and J. F. Markmann (2013). "Elevated levels of interferon-gamma production by memory T cells do not promote transplant tolerance resistance in aged recipients." PLoS One 8(12): e82856.
  103. Martins, P. N. and J. F. Markmann (2013). "Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin." J Surg Res 185(1): e19-21.
  104. Lee J, Sugiyama T, Liu Y, Wang J, Gu X, Lei Ji, Markmann, JF, Miyazaki S, Miyazaki J, Szot GL, Bottino R, Kim SK. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. eLife 2013;2: e00940. PMID: 24252877. PMCID: PMC3826580.
  105. Markmann, J. F. and T. Kawai (2012). "The quest for transplantation tolerance: have we finally sipped from the cup?" Sci Transl Med 4(124): 124fs125.
  106. Martins, P. N., M. C. Varma, N. Elias and J. F. Markmann (2012). "Image of the month. Portal vein gas associated with pneumatosis intestinalis." Arch Surg 147(3): 291-292.
  107. Lee, K. M., J. I. Kim, R. Stott, J. Soohoo, M. R. O'Connor, H. Yeh, G. Zhao, P. Eliades, C. Fox, N. Cheng, S. Deng and J. F. Markmann (2012). "Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells." Am J Transplant 12(8): 2072-2078.
  108. Zhao G, Moore DJ, Kim JI, Lee KM, O'Connor MR, Duff PE, Lei Ji, Markmann JF, Deng S. Inhibition of transplantation tolerance by immune senescence is reversed by endocrine modulation. Sci Transl Med 2011;3(87):87ra52. PMID: 21677198.
  109. Kim, J. I., R. O'Connor M, P. E. Duff, G. Zhao, K. M. Lee, P. Eliades, S. Deng, H. Yeh, A. J. Caton and J. F. Markmann (2011). "Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols." Transplantation 91(7): 707-713.
  110. Markmann, J. F. and J. A. Fishman (2011). "Alemtuzumab in kidney-transplant recipients." N Engl J Med 364
  111. Pisania A, Weir GC, O'Neil JJ, Omer A, Tchipashvili V, Lei Ji, Colton CK, Bonner-Weir S. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest 2010;90(11):1661-75. PMID: 20697378.
  112. Christian Schuetz, Ping Wang,  Aseda Tena,  Zurab Machaidze , Zdravka Medarova,  Ji Lei,  L Bühler,  Shaoping Deng, James F, Markmann, David H Sachs, Anna Moore, In vivio MRI monitoring of the transplanted autologous islet- correlation with morphology, function and graft survival. Transplantation, Published on 01 Jul 2010
  113. Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE, O'Connor MR, Lei Ji, Hirohashi T., Yang M, Markmann JF, Deng S. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant 2010;10(4):796-801. PMID: 20199511.
  114. Saidi, R. F., J. Bradley, D. Greer, R. Luskin, K. O'Connor, F. Delmonico, P. Kennealey, F. Pathan, C. Schuetz, N. Elias, D. S. Ko, T. Kawai, M. Hertl, A. B. Cosimi and J. F. Markmann (2010). "Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death?" Am J Transplant 10(11): 2536-2540.
  115. Kim, J. I., S. B. Sonawane, M. K. Lee, S. H. Lee, P. E. Duff, D. J. Moore, M. R. O'Connor, M. M. Lian, S. Deng, Y. Choi, H. Yeh, A. J. Caton and J. F. Markmann (2010). "Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival." Eur J Immunol 40(5): 1369-1374.
  116. Reese, P. P., H. Yeh, A. M. Thomasson, J. Shults and J. F. Markmann (2009). "Transplant center volume and outcomes after liver retransplantation." Am J Transplant 9(2): 309-317.
  117. Kim, J. I., M. K. t. Lee, D. J. Moore, S. B. Sonawane, P. E. Duff, M. R. O'Connor, H. Yeh, M. M. Lian, S. Deng, A. J. Caton and J. F. Markmann (2009). "Regulatory T-cell counter-regulation by innate immunity is a barrier to transplantation tolerance." Am J Transplant 9(12): 2736-2744.
  118. Sonawane, S. B., J. I. Kim, M. K. Lee, S. H. Lee, P. E. Duff, D. J. Moore, M. M. Lian, S. Deng, Y. Choi, H. Yeh, A. J. Caton and J. F. Markmann (2009). "GITR Blockade Facilitates Treg Mediated Allograft Survival." Transplantation 88(10): 1169-1177.
  119. Reich, D. J., D. C. Mulligan, P. L. Abt, T. L. Pruett, M. M. Abecassis, A. D'Alessandro, E. A. Pomfret, R. B. Freeman, J. F. Markmann, D. W. Hanto, A. J. Matas, J. P. Roberts, R. M. Merion, G. B. Klintmalm and A. S. o. O. T. Committee (2009). "ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation." Am J Transplant 9(9): 2004-2011.
  120. Yeh, H. and J. F. Markmann (2008). "Tolerance: it's in your blood." Clin Immunol 127(2): 121-122.
  121. Huang, X., D. J. Moore, M. Mohiuddin, M. M. Lian, J. I. Kim, S. Sonawane, J. Wang, Y. Gu, H. Yeh, J. F. Markmann and S. Deng (2008). "Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance." Transplantation 85(5): 675-680.
  122. Markmann, J. F., D. B. Kaufman, C. Ricordi, P. M. Schwab and P. G. Stock (2008). "Financial issues constraining the use of pancreata recovered for islet transplantation: a white paper." Am J Transplant 8(8): 1588-1592.
  123. Reese, P. P., S. B. Sonawane, A. Thomasson, H. Yeh and J. F. Markmann (2008). "Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival." Transplantation 85(12): 1737-1744.
  124. Moore, D. J., J. I. Kim, S. Sonawane, H. Yeh, S. Deng, K. t. Lee and J. F. Markmann (2007). "Progress toward antibody-induced transplantation tolerance." Crit Rev Immunol 27(2): 167-218.
  125. Deng, S., D. J. Moore, X. Huang, M. M. Lian, M. Mohiuddin, E. Velededeoglu, M. K. t. Lee, S. Sonawane, J. Kim, J. Wang, H. Chen, S. A. Corfe, C. Paige, M. Shlomchik, A. Caton and J. F. Markmann (2007). "Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes." J Immunol 178(10): 6028-6032.
  126. Porrett, P. M., H. Yeh, A. Frank, S. Deng, J. I. Kim, C. F. Barker and J. F. Markmann (2007). "Availability of suitable islet donors in the United States." Transplantation 84(2): 280-282.
  127. Lee, M. K. t., D. J. Moore, M. Chiaccio, M. M. Lian, S. Deng, M. Mohiuddin, X. Huang, B. KoeberLein, A. Zakheim, P. M. Porrett, C. F. Barker, A. J. Caton and J. F. Markmann (2006). "T-reg mediated suppression of the allograft response in the draining lymph node." Transplantation 81(7): 1063-1066.
  128. Deng, S., D. J. Moore, X. Huang, M. Mohiuddin, M. K. t. Lee, E. Velidedeoglu, M. M. Lian, M. Chiaccio, S. Sonawane, A. Orlin, J. Wang, H. Chen, A. Caton, R. Zhong and J. F. Markmann (2006). "Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells." J Immunol 176(5): 2799-2807.
  129. Dobos, N., D. A. Roberts, E. K. Insko, E. S. Siegelman, A. Naji and J. F. Markmann (2005). "Contrast-enhanced MR angiography for evaluation of vascular complications of the pancreatic transplant." Radiographics 25(3): 687-695.
  130. Frank, A. M., C. F. Barker and J. F. Markmann (2005). "Comparison of whole organ pancreas and isolated islet transplantation for type 1 diabetes." Adv Surg 39: 137-163.
  131. Frank, A., S. Deng, X. Huang, E. Velidedeoglu, Y. S. Bae, C. Liu, P. Abt, R. Stephenson, M. Mohiuddin, T. Thambipillai, E. Markmann, M. Palanjian, M. Sellers, A. Naji, C. F. Barker and J. F. Markmann (2004). "Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets." Ann Surg 240(4): 631-640; discussion 640-633.
  132. Abt, P. L., N. M. Desai, M. D. Crawford, L. M. Forman, J. W. Markmann, K. M. Olthoff and J. F. Markmann (2004). "Survival following liver transplantation from non-heart-beating donors." Ann Surg 239(1): 87-92.
  133. Deng, S., M. Vatamaniuk, X. Huang, N. Doliba, M. M. Lian, A. Frank, E. Velidedeoglu, N. M. Desai, B. KoeberLein, B. Wolf, C. F. Barker, A. Naji, F. M. Matschinsky and J. F. Markmann (2004). "Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects." Diabetes 53(3): 624-632.
  134. Lee, M. K. t., D. J. Moore, B. P. Jarrett, M. M. Lian, S. Deng, X. Huang, J. W. Markmann, M. Chiaccio, C. F. Barker, A. J. Caton and J. F. Markmann (2004). "Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation." J Immunol 172(11): 6539-6544.
  135. Desai, N. M., K. C. Mange, M. D. Crawford, P. L. Abt, A. M. Frank, J. W. Markmann, E. Velidedeoglu, W. C. Chapman and J. F. Markmann (2004). "Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function." Transplantation 77(1): 99-106.
  136. Velidedeoglu, E., K. C. Mange, A. Frank, P. Abt, N. M. Desai, J. W. Markmann, R. Reddy and J. F. Markmann (2004). "Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients." Transplantation 77(12): 1834-1842.
  137. Sellers, M. T., E. Velidedeoglu, R. D. Bloom, R. A. Grossman, J. W. Markmann, A. Naji, A. M. Frank, A. B. Kass, H. M. Nathan, R. D. Hasz, J. D. Abrams and J. F. Markmann (2004). "Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation." Transplantation 78(11): 1670-1675.
  138. Velidedeoglu, E., R. D. Bloom, M. D. Crawford, N. M. Desai, L. Campos, P. L. Abt, J. W. Markmann, K. C. Mange, K. M. Olthoff, A. Shaked and J. F. Markmann (2004). "Early kidney dysfunction post liver transplantation predicts late chronic kidney disease." Transplantation 77(4): 553-556.
  139. Markmann, J. F., S. Deng, N. M. Desai, X. Huang, E. Velidedeoglu, A. Frank, C. Liu, K. L. Brayman, M. M. Lian, B. Wolf, E. Bell, M. Vitamaniuk, N. Doliba, F. Matschinsky, E. Markmann, C. F. Barker and A. Naji (2003). "The use of non-heart-beating donors for isolated pancreatic islet transplantation." Transplantation 75(9): 1423-1429.
  140. Lee, M. K. t., D. J. Moore and J. F. Markmann (2003). "Regulatory CD4+CD25+T cells in prevention of allograft rejection." Front Biosci 8: s968-981.
  141. Markmann, J. F., J. W. Markmann, N. M. Desai, A. Baquerizo, J. Singer, H. Yersiz, C. Holt, R. M. Ghobrial, D. G. Farmer and R. W. Busuttil (2003). "Operative parameters that predict the outcomes of hepatic transplantation." J Am Coll Surg 196(4): 566-572.
  142. Markmann, J. F., M. Rosen, E. S. Siegelman, M. C. Soulen, S. Deng, C. F. Barker and A. Naji (2003). "Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?" Diabetes 52(7): 1591-1594.
  143. Markmann, J. F., S. Deng, X. Huang, N. M. Desai, E. H. Velidedeoglu, C. Lui, A. Frank, E. Markmann, M. Palanjian, K. Brayman, B. Wolf, E. Bell, M. Vitamaniuk, N. Doliba, F. Matschinsky, C. F. Barker and A. Naji (2003). "Insulin independence following isolated islet transplantation and single islet infusions." Ann Surg 237(6): 741-749; discussion 749-750.
  144. Deng, S., M. Vatamaniuk, M. M. Lian, N. Doliba, J. Wang, E. Bell, B. Wolf, S. Raper, F. M. Matschinsky and J. F. Markmann (2003). "Insulin gene transfer enhances the function of human islet grafts." Diabetologia 46(3): 386-393.
  145. Desai, N. M., J. A. Goss, S. Deng, B. A. Wolf, E. Markmann, M. Palanjian, A. P. Shock, S. Feliciano, F. C. Brunicardi, C. F. Barker, A. Naji and J. F. Markmann (2003). "Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?" Transplantation 76(11): 1623-1625.
  146. Trani, J., D. J. Moore, B. P. Jarrett, J. W. Markmann, M. K. Lee, A. Singer, M. M. Lian, B. Tran, A. J. Caton and J. F. Markmann (2003). "CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance." J Immunol 170(1): 279-286.
  147. Velidedeoglu, E., B. Jarret, K. Lee, D. Moore, X. Huang, S. Deng, M. M. Lian, A. Caton and J. F. Markmann (2002). "Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance." Transplant Proc 34(8): 3342-3344.
  148. Velidedeoglu, E., N. M. Desai, L. Campos, K. M. Olthoff, A. Shaked, F. Nunes, G. Zeldin, C. Stewart, E. Blumberg, J. Abrams and J. F. Markmann (2002). "The outcome of liver grafts procured from hepatitis C-positive donors." Transplantation 73(4): 582-587.
  149. Velidedeoglu, E., M. D. Crawford, N. M. Desai, L. Campos, P. L. Abt, J. W. Markmann, K. C. Mange, R. Bloom, K. M. Olthoff, A. Shaked and J. F. Markmann (2002). "Predictors of late kidney dysfunction post-liver transplantation." Transplant Proc 34(8): 3315-3316.
  150. Velidedeoglu, E., N. Williams, K. L. Brayman, N. M. Desai, L. Campos, M. Palanjian, M. Wocjik, R. Bloom, R. A. Grossman, K. Mange, C. F. Barker, A. Naji and J. F. Markmann (2002). "Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy." Transplantation 74(2): 169-172.
  151. Gorczynski RM, Hu J, Chen Z, Kai Y, Lei Ji. A CD200FC immunoadhesin prolongs rat islet xenograft survival in mice. Transplantation 2002;73(12):1948-53. PMID: 12131694.
  152. Velidedeoglu, E., N. Williams, K. L. Brayman, N. M. Desai, L. Campos, M. Palanjian, M. Wocjik, R. Bloom, R. Grossman, K. Mange, J. Buyske, C. F. Barker, A. Naji and J. F. Markmann (2001). "Surgical options for live-donor nephrectomy." Transplant Proc 33(7-8): 3789-3790.
  153. Markmann, J. F., J. W. Markmann, D. A. Markmann, A. Bacquerizo, J. Singer, C. D. Holt, J. Gornbein, H. Yersiz, M. Morrissey, S. M. Lerner, S. V. McDiarmid and R. W. Busuttil (2001). "Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants." Transplantation 72(6): 1113-1122.
  154. Markmann, J. F. and A. Shaked (2001). "Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation 2001; 72: 1432." Transplantation 72(8): 1351-1352.
  155. Velidedeoglu, E., N. M. Desai, L. Campos, K. M. Olthoff, A. Shaked, F. Nunes, G. Zeldin, C. Stewart, E. Blumberg, J. Abrams and J. F. Markmann (2001). "Effect of donor hepatitis C on liver graft survival." Transplant Proc 33(7-8): 3795-3796.
  156. Trani, J. L., H. K. Song, S. M. Lerner, J. W. Markmann, C. F. Barker, A. Naji and J. F. Markmann (2001). "Comparison of activation requirements and activation phenotype of allogeneic and xenogeneic rodent responses in vivo and in vitro." Transplantation 72(3): 485-491.
  157. Gorczynski R, Bransom J, Cattral M, Huang X, Lei Ji, Min W, Wan Y, Gauldie J. Dendritic cells expressing TGFbeta/IL-10, and CHO cells with OX-2, increase graft survival. Transplantation Proc 2001;33(1-2):1565-6. PMID: 11267422.
  158. Gorczynski RM, Chen Z, Hu J, Kai Y, Lei Ji. Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice. Clin Exp Immunol 2001;126(2):220-9. PMID: 11703364.
  159. Markmann, J. F., L. Campos, E. Velidedeoglu, T. S. Guy, S. L. Moainie, N. M. Desai, R. C. Gorman, K. L. Brayman, A. Naji and C. F. Barker (2000). "Annual literature review--clinical transplants 2000." Clin Transpl: 411-465.
  160. Gorczynski RM, Bransom J, Cattral M, Huang X, Lei Ji, Xiaorong L, Min WP, Wan Y, Gauldie, J. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2. Clin Immunol 2000;95(3):182-9. PMID: 10866124.
  161. Gorczynski RM, Chen Z, Kai Y, Lei Ji. Evidence for persistent expression of OX2 as a necessary component of prolonged renal allograft survival following portal vein immunization. Clin Immunol 2000;97(1):69-78. PMID: 10998319.
  162. Min WP, Gorczynski R, Huang XY, Kushida M, Kim P, Obataki M, Lei Ji, Suri, RM, Cattral, MS. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000;164(1):161-7. PMID: 10605007.
  163. Gorczynski RM, Cattral MS, Chen Z, Hu J, Lei Ji, Min WP, Yu G, Ni J. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol 1999;163(3):1654-60. PMID: 10415071.
  164. Gorczynski RM, Cohen Z, Fu XM, Lei Ji. Anti-rat OX-2 blocks increased small intestinal transplant survival after portal vein immunization. Transplantation Proc 1999;31(1-2):577-8. PMID: 10083244.
  165. Ramakrishna V, Hu J, Lei Ji, Li X, Gorczynski RM. Alterations in chemokine mRNA expression in animals receiving portal vein immunization and renal allo- or xenotransplantation precede altered cytokine production. J Surg Res 1999;87(1):62-72. PMID: 10527705.
  166. Markmann, J. F., J. Gornbein, J. S. Markowitz, M. F. Levy, G. B. Klintmalm, H. Yersiz, M. Morrisey, K. Drazan, D. G. Farmer, R. M. Ghobrial, J. Goss, P. Seu, P. Martin, L. I. Goldstein and R. W. Busuttil (1999). "A simple model to estimate survival after retransplantation of the liver." Transplantation 67(3): 422-430.
  167. Gorczynski L, Chen Z, Hu J, Kai Y, Lei Ji, Ramakrishna V, Gorczynski RM. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J Immunol 1999;162(2):774-81. PMID: 9916698. 
  168. Song Y, Yang Z, Lei Ji. Experimental study on the efficacy of methyl prednisolone in the treatment of traction injury of spinal cord in rabbits. Chinese journal of reparative and reconstructive surgery 1998;12(5):261-5. PMID: 10437099.
  169. Markmann, J. F., J. S. Markowitz, H. Yersiz, M. Morrisey, D. G. Farmer, D. A. Farmer, J. Goss, R. Ghobrial, S. V. McDiarmid, R. Stribling, P. Martin, L. I. Goldstein, P. Seu, C. Shackleton and R. W. Busuttil (1997). "Long-term survival after retransplantation of the liver." Ann Surg 226(4): 408-418; discussion 418-420.
  170. DeMatteo, R. P., G. Chu, M. Ahn, E. Chang, C. F. Barker and J. F. Markmann (1997). "Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression." J Virol 71(7): 5330-5335.
  171. DeMatteo, R. P., G. Chu, M. Ahn, E. Chang, C. Burke, S. E. Raper, C. F. Barker and J. F. Markmann (1997). "Immunologic barriers to hepatic adenoviral gene therapy for transplantation." Transplantation 63(2): 315-319.
  172. Ahn, M., C. Sohn, E. Chang, G. Chu, R. P. DeMatteo, C. F. Barker and J. F. Markmann (1996). "Role of humoral immunity in pancreatic islet allo- and xenograft rejection." Transplant Proc 28(2): 840-841.
  173. Campos, L., A. Naji, B. C. Deli, J. H. Kern, J. I. Kim, C. F. Barker and J. F. Markmann (1995). "Survival of MHC-deficient mouse heterotopic cardiac allografts." Transplantation 59(2): 187-191.
  174. Campos, L., B. C. Deli, J. H. Kern, J. I. Kim, A. Naji, C. F. Barker and J. F. Markmann (1995). "Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts." Transplant Proc 27(1): 254-255.
  175. DeMatteo, R. P., S. E. Raper, M. Ahn, K. J. Fisher, C. Burke, A. Radu, G. Widera, B. R. Claytor, C. F. Barker and J. F. Markmann (1995). "Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus." Ann Surg 222(3): 229-239; discussion 239-242.
  176. Ahn, M., E. Chang, G. Chu, C. F. Barker and J. F. Markmann (1995). "Cellular requirements for pancreatic islet xenograft rejection." Transplant Proc 27(6): 3302-3303.
  177. Markmann, J. F., N. M. Desai, H. Bassiri, J. I. Kim and C. F. Barker (1994). "Prolonged survival of class I deficient mouse islet allografts but not xenografts." Transplant Proc 26(2): 748.
  178. Markmann, J. F., L. Campos, A. Bhandoola, J. I. Kim, N. M. Desai, H. Bassiri, B. R. Claytor and C. F. Barker (1994). "Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts." Surgery 116(2): 242-248; discussion 248-249.
  179. Markmann, J. F. and C. F. Barker (1994). "Basic and clinical considerations in the use of xenografts." Curr Probl Surg 31(5): 387-460.
  180. Desai, N. M., H. Bassiri, J. S. Odorico, B. H. Koller, O. Smithies, A. Naji, C. F. Barker and J. F. Markmann (1993). "Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients." Transplant Proc 25(1 Pt 2): 961-962.
  181. Desai, N. M., H. Bassiri, J. Kim, B. H. Koller, O. Smithies, C. F. Barker, A. Naji and J. F. Markmann (1993). "Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice." Transplantation 55(4): 718-722.
  182. Markmann, J. F., H. Bassiri, N. M. Desai, J. I. Kim, J. S. Odorico and C. F. Barker (1993). "Donor antigen-specific T-lymphocyte deletion after intrathymic inoculation." Transplant Proc 25(1 Pt 1): 305-306.
  183. Markmann, J. F., J. S. Odorico, H. Bassiri, N. Desai, J. I. Kim and C. F. Barker (1993). "Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells." Transplantation 55(4): 871-876; discussion 876-877.
  184. Barker, C. F. and J. F. Markmann (1992). "Xenografts: is there a future?" Surgery 112(1): 3-5.
  185. Markmann, J. F., H. Bassiri, N. M. Desai, J. S. Odorico, J. I. Kim, B. H. Koller, O. Smithies and C. F. Barker (1992). "Indefinite survival of MHC class I-deficient murine pancreatic islet allografts." Transplantation 54(6): 1085-1089.
  186. Shachner, M. S., A. Naji, C. F. Barker and J. F. Markmann (1991). "The in vitro immunogenicity of antigen-presenting cell-free endocrine cells: the role of antigen presenting cells." Transplant Proc 23(1 Pt 1): 89-90.
  187. Markmann, J. F., A. M. Posselt, H. Bassiri, K. L. Brayman, M. Woehrle, W. F. Hickey, W. K. Silvers, C. F. Barker and A. Naji (1991). "Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats." Transplantation 52(4): 662-667.
  188. Markmann, J. F., J. Tomaszewski, A. M. Posselt, M. M. Levy, M. Woehrle, C. F. Barker and A. Naji (1990). "The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression." Transplantation 49(2): 272-277.
  189. Markmann, J. F., M. S. Schachner, H. Bassiri, C. F. Barker and A. Naji (1990). "The contribution of MHC antigen modulation to islet allograft rejection." Horm Metab Res Suppl 25: 104-108.
  190. Markmann, J. F., M. Woehrle, A. Roza, C. F. Barker and A. Naji (1990). "Islet transplantation to study autoimmune pathogenesis of diabetes in BB rat." Horm Metab Res Suppl 25: 116-119.
  191. Markmann, J. F., C. F. Barker, D. Lo, R. Brinster, J. Tomaszewski and A. Naji (1990). "Islet endocrine cell MHC antigen expression in allograft rejection." Transplant Proc 22(2): 847-848.
  192. Markmann, J. F., A. M. Posselt, M. Levy, A. Naji and C. F. Barker (1990). "Immunologic consequences of islet MHC antigen modulation in autoimmune diabetes." Transplant Proc 22(2): 849-850.
  193. Markmann, J. F., C. F. Barker, D. Lo, R. Brinster, E. Heber-Katz and A. Naji (1990). "Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness." Transplant Proc 22(4): 2052-2053.
  194. Markmann, J. F., J. D. Jacobson, K. L. Brayman, H. Kimura, C. F. Barker and A. Naji (1989). "Prevention of recurrent diabetes in BB rats after islet transplantation by monoclonal antibody therapy." Diabetes 38 Suppl 1: 165-167.
  195. Markmann, J. F., J. Jacobson, H. Kimura, K. L. Brayman, C. F. Barker and A. Naji (1989). "Prevention of autoimmune damage to islet grafts in BB rats by antibody therapy." Transplant Proc 21(1 Pt 3): 2703-2704.
  196. Markmann, J. F., J. D. Jacobson, H. Kiumura, M. A. Choti, W. F. Hickey, I. J. Fox, W. K. Silvers, C. F. Barker and A. Naji (1989). "Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts." Transplantation 48(3): 478-486.
  197. Markmann, J. F., H. F. Bassiri, C. F. Barker and A. Naji (1989). "Effect of lymphokine-induced MHC antigen expression on islet allograft survival." Transplant Proc 21(1 Pt 3): 2723-2724.
  198. Markmann, J. F., A. Naji, C. F. Barker and K. L. Brayman (1988). "Immunomodulation of pre-diabetes in BB rats for prevention of the disease." Adv Exp Med Biol 246: 357-364.
  199. Markmann, J. F., D. P. Markmann, J. D. Balshi and A. Naji (1987). "Retransplantation of rat islet allografts following residence in an interim host." Transplant Proc 19(1 Pt 2): 940-941.
  200. Markmann, J. F., W. F. Hickey, H. Kimura, M. Woehrle, C. F. Barker and A. Naji (1987). "Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells." Pancreas 2(3): 258-261.